公开(公告)号：US20240393334A1

公开(公告)日：2024-11-28

申请号：US18743218

申请日：2024-06-14

Applicant: Abbott Laboratories

Inventor： Tony K. Lee ,  Peter J. Karabatsos ,  Andrew S. Schapals ,  Antti Virtanen ,  Beth McQuiston ,  Craig A. Jeffrey ,  Alison Taylor ,  Raj Chandran ,  Jaime Marino ,  Saul Datwyler

IPC: G01N33/573 ,  A61B5/15 ,  G01N33/68 ,  G01N33/76 ,  G01N33/78

Abstract: Disclosed herein are systems and methods for determining ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), glial fibrillary acidic protein (GFAP), or a combination thereof in a blood sample obtained from a subject. Also disclosed herein are systems and methods for determining CK-MB, β-hCG, thyroid stimulating hormone (TSH), homocysteine, free thyroxine (free T4) or any combinations thereof in a blood sample.

公开(公告)号：US20240003916A1

公开(公告)日：2024-01-04

申请号：US18353371

申请日：2023-07-17

Applicant: Abbott Laboratories

Inventor： Antti Virtanen ,  Cary James MILLER

IPC: G01N33/68 ,  G01N33/543

CPC classification number: G01N33/6893 ,  G01N33/54386 ,  G01N33/54326 ,  G01N2333/4756 ,  G01N2800/2871 ,  G01N2470/04

Abstract: Disclosed herein are systems and assays that employ magnetically susceptible beads and point-of-care devices comprising magnetic immunosensors to determine the amount of glial fibrillary acidic protein (GFAP) in a biological sample obtained from a subject.

公开(公告)号：US20230082323A1

公开(公告)日：2023-03-16

申请号：US17934810

申请日：2022-09-23

Applicant: Abbott Laboratories

Inventor： Antti Virtanen ,  Jake Bezaire

IPC: G01N33/569 ,  G01N33/68

Abstract: Disclosed herein are methods, complexes, kits, systems and algorithms for detecting or determining an amount, quantity, concentration and/or level of at least one type of anti-β-coronavirus antibody, such as, for example, an anti-SARS-CoV antibody or anti-SARS-CoV-2 antibody (including an IgA, IgG and/or an IgM antibody), in one or more samples obtained from a subject.